The Papanicolaou smear: Its value and limitations

Journal of Family Practice

Volumn 42, Issue 4, 1996, Pages 391-399

  Lieu, David ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Merrithew Memorial Hospital   (United States)

Author keywords

gynecology, cytology, limitations; Pap smear

Indexed keywords

ALGORITHM; AUTOMATION; CANCER RISK; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HUMAN; PAPANICOLAOU TEST; PATIENT EDUCATION; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR CLASSIFICATION; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR;

ALGORITHMS; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0029972664     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Barter JH. The life and contributions of Doctor George Nicholas Papanicolaou. Gynecol Obstet 1992; 174:530-2.
2. Dehner LP. Cervicovaginal cytology, false negative results, and standards of practice. Am J Clin Pathol 1993; 99:45-7.
3. Schiffman MH, Bauer HM, Hoover RN. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85:958-64.
4. Wright TC, Richart RM. Role of human papillomavirus in the pathogenesis of genital tract warts and cancer. Gynecol Oncol 1990; 37:151-64.
5. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993; 12:186-92.
6. Kristensen GB, Skyggebjerg KD, Holund B. Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer. Acta Cytol 1991; 35:47-50.
7. Wilkinson CE, Peters TJ, Stott NCH. Prospective evaluation of a risk scoring system for cervical neoplasia in primary care. Br J Gen Pract 1994; 44:341-4.
8. Papanicolaou GN. Atlas of exfoliative cytology. Cambridge, Mass: The Commonwealth Fund, 1954.
9. Crocker J, Fox H, Langley FA. Consistency in the histological diagnosis of epithelial abnormalities of the cervix. J Clin Pathol 1968; 21:67.
10. Sherman ME, Schiffman MH, Lorincz AT. Toward objective quality assurance in cervical cytopathology. Am J Clin Pathol 1994; 102:182-7.
11. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. JAMA 1989; 262:931-4.
12. National Cancer Institute Workshop. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Report of the 1991 Bethesda Workshop. JAMA 1992; 16:914-6.
13. Kurman RJ, Solomon D. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. New York, NY: Springer-Verlag, 1994.
14. Sidawy MK, Tabbara SO, Silverberg SG. Should we report cervical smears lacking endocervical component as unsatisfactory? Diagn Cytopathol 1992; 8:567-70.
15. Davey DD, Naryshkin S, Lielson ML. Atypical squamous cells of undetermined significance. Diagn Cytopathol 1994; 11:390-6.
16. Shells LA, Wilbur DC. The significance of atypical cells of squamous type (AS) on Papanicolaou smears: a five-year follow-up study. Acta Cytol 1992; 36:580.
17. Kurman RJ, Henson DK, Herbst AL, et al. Interim guidelines for management of abnormal cervical cytology. JAMA 1994; 271:1866-9.
18. Nasca PC, Ellish N, Caputo TA. An epidemiologic study of Pap screening histories in women with invasive carcinomas of the cervix. NY State J Med 1991; 91:152-6.
19. Crum CP. Female genital tract. In: Robbins pathologic basis of disease. 5th ed. Philadelphia, Pa: WB Saunders, 1994:1033-88.
20. Parkin MD. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988; 41;184-97.
21. Hakama H. Trends in the incidence of cervical cancers in Nordic countries. In: Magnus K. Trends in cancer incidence. New York, NY: Hemisphere, 1982:279-92.
22. Miller AB, Lindsay J, Hill JB. Mortality from cancer of the uterus in Canada and relationship to screening for cancer of the cervix. Int J Cancer 1976; 17:602-12.
23. Pretorius R, Semrad N, Watring W. Presentation of cervical cancer. Gynecol Oncol 1991; 42:48-53.
24. Koss LG. The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. JAMA 1989; 261:734-43.
25. Jones BA. Q-probes. Pap smear rescreening data analysis and critique. Northfield, Ill: College of American Pathologists, 1993:93-103.
26. Koss LG. Cervical (Pap) smear. New directions. Cancer 1993; 71:1406-12.
27. Krieger P, Naryshkin S. Random rescreening of cytologic smears: a practical and effective component of quality assurance programs in both large and small cytology laboratories. Acta Cytol 1994; 38:291-8.
28. Hatem F, Wilbur DC. High-grade squamous cervical lesions following negative Papanicolaou smears. Diagn Cytopathol 1995; 12:135-41.
29. Kline TJ. Cytopathology: negligence and a lawyer's opinion. Diagn Cytopathol 1994; 11:219.
30. Frable WJ. Litigation cells. Diagn Cytopathol 1994; 11:213-5.
31. Bosch MM, Rietveld-Scheffers PE, Boon ME. Characteristics of false-negative smears in the normal screening situation. Acta Cytol 1992; 36:711.
32. Klinkhamer PJ, Vooijs GP, de Haan AFJ. Intraobserver and interobserver variability in the diagnosis of epithelial abnormalities in cervical smears. Acta Cytol 1988; 32:794-800.
33. Hall S, Wu TC, Soudi N. Low-grade squamous intraepithelial lesions. Diagn Cytopathol 1994; 10:3-9.
34. Koss LG. Diagnostic accuracy in cervicovaginal cytology. Arch Pathol Lab Med 1993; 117:1240-2.
35. Check WA. PAP devices seek to star in clinical galaxy. CAP Today 1995; 9:1, 24-31.
36. Beral V, Day NE. Screening for cervical cancer: is there a place for incorporating tests for the human papillomavirus? In: Munoz N, Bosch FX, Shah KV, eds. The epidemiology of cervical cancer and human papillomavirus. Lyon, France: International Agency for Research on Cancer, 1992:263-9.
37. Robb J. The Pap smear is a cancer screening test: why not put the screening error rate in the report: Diagn Cytopathol 1993; 9:485-6.
38. Mitchell H. Cancer screening: protecting the public's health. Diagn Cytopathol 1995; 12:199-200.
39. Gambino R. The imperfect Pap test. Lab Report 1995; 17:16.
40. Gambino R. Cytology regulations may not have intended effect. Lab Report 1992; 14:86-7.